Suppr超能文献

基于纤维蛋白的再生性根管充填材料中的牙髓来源外泌体

Pulp-Derived Exosomes in a Fibrin-Based Regenerative Root Filling Material.

作者信息

Ivica Anja, Ghayor Chafik, Zehnder Matthias, Valdec Silvio, Weber Franz E

机构信息

Oral Biotechnology and Bioengineering; Center for Dental Medicine, University of Zurich, 8032 Zurich, Switzerland.

Preventive Dentistry, Periodontology and Cariology, Center for Dental Medicine, University of Zurich, 8032 Zurich, Switzerland.

出版信息

J Clin Med. 2020 Feb 11;9(2):491. doi: 10.3390/jcm9020491.

Abstract

Regenerative endodontics has been described as a paradigm shift in dentistry, despite its current limitation to immature teeth and reparative rather than regenerative outcomes. Cell-free treatments are favored because of regulatory issues. However, the recruitment of host-derived stem cells to the desired site remains challenging. We investigated whether dental pulp-derived exosomes, which are extracellular vesicles that contain proteins, lipids, RNA, and DNA and thus mirror their parental cells, may be used for this purpose. The use of exosomes may present appreciable advantages over the direct use of transplanted stem cells due to a higher safety profile, easier isolation, preservation, and handling. Here we harvested exosomes from a cultured third-molar pulp cell and assessed them by transmission electron microscopy and Western blotting. Human mesenchymal stem cells (MSCs) were exposed to these exosomes to assess exosome uptake, cell migration, and proliferation. In addition, a fibrin gel (i.e., a diluted fibrin sealant), was assessed as a delivery system for the exosomes. Our results show that exosomes attracted MSCs, and the fibrin gel enhanced their effect. Moreover, exosomes improved the proliferation of MSCs. Therefore, we propose that pulp-derived exosomes in combination with a fibrin gel could be a powerful combination for clinical translation towards improved cell-free regenerative endodontics and thus represent a new way to fill dental hard tissues.

摘要

再生牙髓治疗学被认为是牙科领域的一次范式转变,尽管其目前仅限于未成熟牙齿,且治疗结果是修复而非再生。由于监管问题,无细胞治疗受到青睐。然而,将宿主来源的干细胞招募到所需部位仍然具有挑战性。我们研究了牙髓来源的外泌体——一种包含蛋白质、脂质、RNA和DNA并因此反映其亲代细胞特征的细胞外囊泡——是否可用于此目的。由于更高的安全性、更易于分离、保存和处理,使用外泌体可能比直接使用移植干细胞具有明显优势。在这里,我们从培养的第三磨牙牙髓细胞中收获外泌体,并通过透射电子显微镜和蛋白质印迹法对其进行评估。将人间充质干细胞(MSCs)暴露于这些外泌体中,以评估外泌体的摄取、细胞迁移和增殖。此外,还评估了纤维蛋白凝胶(即稀释的纤维蛋白封闭剂)作为外泌体的递送系统。我们的结果表明,外泌体吸引了MSCs,并且纤维蛋白凝胶增强了它们的作用。此外,外泌体促进了MSCs的增殖。因此,我们提出牙髓来源的外泌体与纤维蛋白凝胶相结合可能是朝着改进的无细胞再生牙髓治疗学进行临床转化的有力组合,从而代表了一种填充牙齿硬组织的新方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3a2/7074310/168a991be694/jcm-09-00491-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验